Downregulation of miR-217 correlates with resistance of Ph(+) leukemia cells to ABL tyrosine kinase inhibitors.
about
The Role of MicroRNAs in Myeloproliferative NeoplasiaManaging Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene TherapyClinical significance of microRNAs in chronic and acute human leukemiaThe functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapyTherapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAsmiR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5MicroRNA-9 plays a role in interleukin-10-mediated expression of E-cadherin in acute myelogenous leukemia cellsMicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism.MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia.miR-30a Regulates the Expression of CAGE and p53 and Regulates the Response to Anti-Cancer DrugsMicroRNA-130a regulates cell malignancy by targeting RECK in chronic myeloid leukemia.miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2.Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies.Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis.MicroRNAs as prognostic biomarker and relapse indicator in leukemia.MicroRNA-541 promotes the proliferation of vascular smooth muscle cells by targeting IRF7.Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma.Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment.Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia.MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer.
P2860
Q26739435-31FFE961-0B48-4693-A93A-A918701B4F76Q26749037-345A1978-4FD4-4186-AC10-8AD2E4DFB71CQ26749533-4D34A45B-8153-48A1-8FF8-FF396C898FAFQ26778301-07B74687-4E8D-4329-9970-0CA1D95D4690Q28071427-5916D086-50D9-4CDC-81CE-64FCEE4E2720Q33596743-AF6DCA58-6440-4131-BE2C-87047D3787F0Q33607590-2680229F-B885-4F9E-B490-E39FCD43FB2CQ35643217-4BDBC44D-1E30-4EA5-B016-42BE8FC9062EQ35905863-B991EA46-9CEF-4AD2-AA3E-14606B009CADQ36835365-DABD90D2-A724-461E-A58A-EE9249F09FBCQ36841290-F87A8D7B-9E04-4B29-B7FF-4316730A65D9Q36962950-FB408AD4-3642-49A3-8F86-56367A82FE52Q37644988-635ED3B8-D446-4541-8C7C-3AA02CFF5B34Q38476564-D5B86C5F-FA0F-4CFB-8C39-4808ABB148E9Q38907220-1E984AB6-ADB7-441A-9464-F890F8F828DDQ39167466-251AB4F3-AB45-43FC-8B5D-8DBBF915B25FQ40683578-6B815651-DC6E-4415-A550-31F70EFBDB83Q41593099-F6CFC7DF-26F3-4B1C-93AB-A0CC42303CC5Q50123249-AC59940C-B847-4EAF-8B96-1BC11C083724Q50240916-6E1B3672-54AD-4A85-886E-A2DB65F9F60DQ55398521-1A103635-E05C-4264-A4D7-92F9FE09B6CB
P2860
Downregulation of miR-217 correlates with resistance of Ph(+) leukemia cells to ABL tyrosine kinase inhibitors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Downregulation of miR-217 corr ...... BL tyrosine kinase inhibitors.
@ast
Downregulation of miR-217 corr ...... BL tyrosine kinase inhibitors.
@en
type
label
Downregulation of miR-217 corr ...... BL tyrosine kinase inhibitors.
@ast
Downregulation of miR-217 corr ...... BL tyrosine kinase inhibitors.
@en
prefLabel
Downregulation of miR-217 corr ...... BL tyrosine kinase inhibitors.
@ast
Downregulation of miR-217 corr ...... BL tyrosine kinase inhibitors.
@en
P2093
P2860
P356
P1433
P1476
Downregulation of miR-217 corr ...... BL tyrosine kinase inhibitors.
@en
P2093
Akihito Yokoyama
Atsuya Nobumoto
Chie Nishioka
Masayuki Tsuda
Takayuki Ikezoe
P2860
P304
P356
10.1111/CAS.12339
P577
2014-01-30T00:00:00Z